ACADIA PHARMACEUTICALS INC shareholders Q3 2023

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 247 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.

ACADIA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Finepoint Capital LP 556,553$11,598,5655.78%
Baker Brothers Advisors 42,864,612$893,298,5145.15%
RTW INVESTMENTS, LP 11,576,537$241,255,0315.09%
Palo Alto Investors LP 2,405,793$50,136,7264.74%
Birchview Capital, LP 240,400$5,009,9364.26%
EcoR1 Capital, LLC 5,991,479$124,862,4224.21%
EMERALD ADVISERS, LLC 1,681,052$35,033,1241.70%
EMERALD MUTUAL FUND ADVISERS TRUST 1,303,988$27,175,1101.64%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 179,702$3,739,5991.26%
SECTOR GAMMA AS 179,785$3,746,7190.96%
RICE HALL JAMES & ASSOCIATES, LLC 696,065$14,505,9950.92%
Frazier Life Sciences Management, L.P. 630,897$13,147,8930.87%
SECTORAL ASSET MANAGEMENT INC 209,960$4,375,5660.85%
Penn Capital Management Company, LLC 289,283$6,049,1410.62%
AlphaCentric Advisors LLC 50,000$1,042,0000.59%
Hood River Capital Management LLC 877,827$18,293,9150.59%
Ghost Tree Capital, LLC 80,000$1,667,2000.55%
Nan Fung Group Holdings Ltd 29,984$624,8670.51%
Soleus Capital Management, L.P. 244,627$5,098,0270.47%
CROWN ADVISORS MANAGEMENT, INC. 30,000$6250.44%
External links

This page lists ACADIA PHARMACEUTICALS INC's shareholders in Q3 2023. To view ACADIA PHARMACEUTICALS INC's shareholder history, click here.